Back | Next |
home / stock / rdgl / rdgl message board
Subject | By | Source | When |
---|---|---|---|
Holding on ,wish I had funds to get more. | BeachDawgNorthwest | investorshub | 07/01/2024 2:40:40 PM |
oversold today, buy opportunity | konshe | investorshub | 07/01/2024 2:36:38 PM |
Most traders in the otc will jump once | wrinklesobw | investorshub | 07/01/2024 2:34:44 PM |
Need to get rid of the impatient traders | mikepgator | investorshub | 07/01/2024 2:31:19 PM |
Let's hope so. | splintered sunlight | investorshub | 07/01/2024 2:26:02 PM |
Ask a MM. They're the ones in control. | WALLnut | investorshub | 07/01/2024 2:22:37 PM |
Ok , not liking this lead balloon. Turn | BeachDawgNorthwest | investorshub | 07/01/2024 2:20:01 PM |
I am aware of that but, the pps | dshade | investorshub | 07/01/2024 2:19:38 PM |
Either do I as this will be a | Tiger Money | investorshub | 07/01/2024 2:19:31 PM |
traders who bought purely for the submission bump | Rum_Tequila | investorshub | 07/01/2024 2:16:57 PM |
Human trials at Mayo costs money.. these prices | den4 | investorshub | 07/01/2024 2:10:23 PM |
Back up when .15 offer done? GLTA | BeachDawgNorthwest | investorshub | 07/01/2024 2:08:18 PM |
Read the rest of it. About being | wrinklesobw | investorshub | 07/01/2024 2:06:32 PM |
60 million shares at $.15. OTC doesnt | Tiger Money | investorshub | 07/01/2024 2:06:29 PM |
News takes 2-3 days to be digested by | BBANBOB | investorshub | 07/01/2024 2:05:19 PM |
Pioneers in dshade exposing themselves in the light | Truthsocial | investorshub | 07/01/2024 2:01:18 PM |
Apparently the value of submission was already baked | kayak_wench | investorshub | 07/01/2024 1:58:20 PM |
Exactly. Day/swings traders controlling the action who are | CatfishHunter | investorshub | 07/01/2024 1:57:07 PM |
9 mil @ .15 isn't a very confident | dshade | investorshub | 07/01/2024 1:56:30 PM |
But it isn't much of drop . I'll | lovethatgreen | investorshub | 07/01/2024 1:55:42 PM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- By Meg Flippin, Benzinga In what could prove to be a transformational development in cancer treatment, Vivos (OTCQB: RDGL), the maker of the Radiogel™ Precision Radionuclide Therapy, submitted an application to the U.S. Food and Drug Administration (FDA) to init...
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing the FDA comments to our previous application (Q211938/S001). Today’...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...